Attached files
| file | filename |
|---|---|
| EX-99.1 - AUDITED FINANCIAL STATEMENTS OF ARTARA SUBSIDIARY, INC. AS OF DECEMBER 31, 2019 - Protara Therapeutics, Inc. | ea119633ex99-1_artaratherap.htm |
| EX-99.2 - UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTS - Protara Therapeutics, Inc. | ea119633ex99-2_artaratherap.htm |
| 8-K/A - AMENDMENT TO FORM 8-K - Protara Therapeutics, Inc. | ea119633-8ka_artaratherap.htm |
Exhibit 23.1
Independent Registered Public Accounting Firm’s Consent
We consent to the inclusion in this Current Report of ArTara Therapeutics, Inc. (formerly Proteon Therapeutics, Inc.) on Form 8-K/A of our report dated March 19, 2020 with respect to our audits of the consolidated financial statements of ArTara Subsidiary, Inc. (formerly ArTara Therapeutics, Inc.) as of December 31, 2019 and 2018 and for the years ended December 31, 2019 and 2018, which report appears in this Form 8-K/A.
/s/ Marcum llp
Marcum llp
New York, NY
March 19, 2020